Biocon, India\u2019s largest biotechnology company, manufactures innovative biopharmaceuticals (medical drugs produced using biotechnology) which cater primarily to high growth areas of diabetology, nephrology, cardiology and oncology. A research-driven company, Biocon has been continuously focusing on bringing out innovative molecules; it launched the world\u2019s first recombinant human insulin \u2018Insugen\u2019.<\/p>\n
But this focus on research and development has led to somewhat muted growth – especially in profitability – over the years, as compared to other pharmaceutical companies. However, recently, it signed a mega marketing deal worth $ 350 million with the world’s largest drug-maker Pfizer to globally commercialise four of its insulin biosimilar products.<\/p>\n
So, what does this deal signal for Biocon\u2019s future?<\/p>\n
And, will the company now capitalize on its R&D investments and shift gears in the future?<\/p>\n","protected":false},"excerpt":{"rendered":"
Biocon, India\u2019s largest biotechnology company, manufactures innovative biopharmaceuticals (medical drugs produced using biotechnology) which cater primarily to high growth areas of diabetology, nephrology, cardiology and oncology. A research-driven company, Biocon has been continuously focusing on bringing out innovative molecules; it launched the world\u2019s first recombinant human insulin \u2018Insugen\u2019. <\/p>\n
But this focus on research and development has led to somewhat muted growth – especially in profitability – over the years, as compared to other pharmaceutical companies. However, recently, it signed a mega marketing deal worth $ 350 million with the world’s largest drug-maker Pfizer to globally commercialise four of its insulin biosimilar products.<\/p>\n
So, what does this deal signal for Biocon\u2019s future?<\/p>\n
And, will the company now capitalize on its R&D investments and shift gears in the future? <\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[821],"tags":[24,131,45],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/posts\/3857"}],"collection":[{"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/comments?post=3857"}],"version-history":[{"count":0,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/posts\/3857\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/media?parent=3857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/categories?post=3857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.moneyworks4me.com\/investmentshastra\/wp-json\/wp\/v2\/tags?post=3857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}